(Reuters) - The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among U.S. doctors, who said the recent withdrawal of an influential COVID-19 study left them wanting to see more data. A pharmacist displays a box of Dexamethasone at the Erasme Hospital amid the coronavirus disease (COVID-19)…
Healthcare affordability. Abortion access. “Medicare for All.” Healthcare was a major force behind the big wins for Democrats in this week’s midterm elections. But the debate over what the Democratic Party will do next is just getting started. KFF Health News chief Washington correspondent Julie Rovner appeared on WAMU’s Health Hub on Nov. 4 to
Generated November 2026 · Clinical Deep Dive Four Fibromyalgia Drugs Are Approved in the US, None in Europe. What Are Regulators Seeing Differently? 0 Comments Your fibromyalgia patient has a diagnosis, a playbook, and a prescription. Only some of that stands on firm ground. The FDA has approved four drugs for fibromyalgia, European regulators refused
You don't have permission to access "http://www.medpagetoday.com/popmedicine/popmedicine/123739" on this server. Reference #18.cb94d817.1793916100.1551aa8 https://errors.edgesuite.net/18.cb94d817.1793916100.1551aa8